Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity

Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity

We have demonstrated that the angiotensin-converting enzyme (ACE) genotype is associated with Alzheimer's disease (AD) in the Japanese population (1Hu J. Miyatake F. Aizu Y. Nakagawa H. Nakamura S. Tamaoka A. Takahashi R. Urakami K. Shoji M. Neurosci. Lett. 1999; 277: 65-67Crossref PubMed Scopu...

Descrición completa

Gardado en:

Detalles Bibliográficos
Main Authors:	Jianguo Hu, Akira Igarashi, Makiko Kamata, Hachiro Nakagawa
Formato:	Artigo
Idioma:	inglés
Publicado:	2001
Acceso en liña:	https://doi.org/10.1074/jbc.m104068200 http://www.jbc.org/article/S0021925819402937/pdf
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares

The N‐terminal active centre of human angiotensin‐converting enzyme degrades Alzheimer amyloid β‐peptide
por: Ryutaro Oba, et al.
Publicado: (2005)

Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ(1–42)) to Aβ(1–40), and Its Inhibition Enhances Brain Aβ Deposition
por: Zou, Kun, et al.
Publicado: (2007)

Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
por: Assarsson, Anna, et al.
Publicado: (2014)

Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
por: Anna Assarsson, et al.
Publicado: (2014)

New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity
por: Yuji Yoshiike, et al.
Publicado: (2001)

Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ<sub>1–42</sub>) to Aβ<sub>1–40</sub>, and Its Inhibition Enhances Brain Aβ Deposition
por: Kun Zou, et al.
Publicado: (2007)

Preventing β-amyloid fibrillization and deposition: β-sheet breakers and pathological chaperone inhibitors
por: Wisniewski, Thomas, et al.
Publicado: (2008)

Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
por: Abelein, Axel, et al.
Publicado: (2015)

Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
por: Axel Abelein, et al.
Publicado: (2015)

Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
por: Joshi, P, et al.
Publicado: (2014)

Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
por: P. Joshi, et al.
Publicado: (2013)

Aβ42-to-Aβ40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
por: Zou, Kun, et al.
Publicado: (2009)

Aβ42-to-Aβ40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
por: Kun Zou, et al.
Publicado: (2009)

TMPyP Inhibits Amyloid-β Aggregation and Alleviates Amyloid-Induced Cytotoxicity
por: Fan, Yujuan, et al.
Publicado: (2017)

Regulation of Steady-state β-Amyloid Levels in the Brain by Neprilysin and Endothelin-converting Enzyme but Not Angiotensin-converting Enzyme
por: Elizabeth A. Eckman, et al.
Publicado: (2006)

The Serpin-Enzyme Complex Receptor Recognizes Soluble, Nontoxic Amyloid-β Peptide but Not Aggregated, Cytotoxic Amyloid-β Peptide
por: Kimberly Boland, et al.
Publicado: (1996)

TDP-43 expression influences amyloid β plaque deposition and tau aggregation
por: Davis, Stephani A., et al.
Publicado: (2017)

TDP-43 expression influences amyloidβ plaque deposition and tau aggregation
por: Stephani A. Davis, et al.
Publicado: (2017)

Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β
por: Korshavn, Kyle J., et al.
Publicado: (2017)

Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β
por: Kyle J. Korshavn, et al.
Publicado: (2017)

The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
por: Garai, Kanchan, et al.
Publicado: (2014)

The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
por: Kanchan Garai, et al.
Publicado: (2014)

Conversion of Aβ43 to Aβ40 by the successive action of angiotensin‐converting enzyme 2 and angiotensin‐converting enzyme
por: Shuyu Liu, et al.
Publicado: (2014)

Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity
por: Du, Wen-Jie, et al.
Publicado: (2015)

Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity
por: Wenjie Du, et al.
Publicado: (2015)

Cytotoxicity of Amyloid β1–42 Fibrils to Brain Immune Cells
por: Mikhail Matveyenka, et al.
Publicado: (2025)

Tanshinones Inhibit Amyloid Aggregation by Amyloid-β Peptide, Disaggregate Amyloid Fibrils, and Protect Cultured Cells
por: Wang, Qiuming, et al.
Publicado: (2013)

Tanshinones Inhibit Amyloid Aggregation by Amyloid-β Peptide, Disaggregate Amyloid Fibrils, and Protect Cultured Cells
por: Qiuming Wang, et al.
Publicado: (2013)

Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor
por: Hemming, Matthew L., et al.
Publicado: (2005)

Kinetic and structural characterization of amyloid‐β peptide hydrolysis by human angiotensin‐1‐converting enzyme
por: Larmuth, Kate M., et al.
Publicado: (2016)

Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor
por: Matthew L. Hemming, et al.
Publicado: (2005)

A New Motif in the N‐Terminal of Acetylcholinesterase Triggers Amyloid‐β Aggregation and Deposition
por: Hou, Li‐Na, et al.
Publicado: (2013)

Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity
por: Jin, Sha, et al.
Publicado: (2016)

Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity
por: Sha Jin, et al.
Publicado: (2016)

β‐Amyloid aggregation and heterogeneous nucleation
por: Srivastava, Atul K., et al.
Publicado: (2019)

β‐Amyloid aggregation and heterogeneous nucleation
por: Atul Srivastava, et al.
Publicado: (2019)

Aggregation and structure of amyloid β-protein
por: Kenjiro Ono, et al.
Publicado: (2021)

Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by Rifampicin
por: Takami Tomiyama, et al.
Publicado: (1996)

Heparin Nanoparticles for β Amyloid Binding and Mitigation of β Amyloid Associated Cytotoxicity
por: Wang, Peng, et al.
Publicado: (2014)

Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
por: Kehoe, Patrick Gavin, et al.
Publicado: (2016)